ClinicalTrials.Veeva

Menu

Study on Doppler Ultrasound Measurement of Changes in Uterine Artery Blood Flow in Normal First Trimester Pregnancies and Its Prediction on Abortion

S

Second Affiliated Hospital of Wenzhou Medical University

Status

Not yet enrolling

Conditions

Abnormal Uteroplacental Circulation

Treatments

Other: Doppler ultrasound measurement of changes in uterine artery blood flow

Study type

Observational

Funder types

Other

Identifiers

NCT06043804
SAHoWMU-CR2023-07-208

Details and patient eligibility

About

Objective:To explore the study of Doppler ultrasound in first trimester pregnancies to measure the change of uterine artery blood flow in normal pregnancies and the prediction on abortion, which provides a certain reference for the change trend of uterine artery blood flow in normal first trimester pregnancies and the prediction of Doppler ultrasound measurement in abortion.

Method:Pregnant women who underwent natural conception and single birth prenatal examination in the Obstetrics Department of the Second Affiliated Hospital of Wenzhou Medical University from October 1, 2023 to December 31, 2025 were selected as the study population. Eligible women were preliminarily screened according to the inclusion conditions of the study objects, and basic information of women in each group was compared: Maternal age, gestational time, birth time, gestational week, abortion history, maternal BMI, maternal MAP, smoking status, serum HCG, subchorionic hematoma, fetal bradycardia, left and right uterine aorta pulse index (PI), resistance index (RI) and systolic/diastolic ratio (S/D), etc. To investigate the effect of Doppler ultrasonography on the measurement of uterine artery blood flow in normal pregnancy and the prediction of abortion.

Enrollment

200 estimated patients

Sex

Female

Ages

16 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Healthy pregnant women Group

Inclusion Criteria:

  1. Intrauterine pregnancy sac and cardiac activity were confirmed by ultrasound examination at 6 weeks;
  2. Complete maternal clinical data;

Exclusion Criteria:

  1. The level of chorionic gonadotropin (HCG) was static or decreased by ultrasonography;
  2. multiple pregnancy;
  3. Patients with congenital uterine malformations, uterine fibroids and any other uterine disease;
  4. Patients who have chronic diseases or are receiving chronic treatment.

Pregnant women with recurrent pregnancy loss Group

Inclusion Criteria:

  1. Intrauterine pregnancy sac and cardiac activity were confirmed by ultrasound examination at 6 weeks;
  2. Complete maternal clinical data;
  3. There has been a history of spontaneous abortion with the same sexual partner for two or more consecutive times;

Exclusion Criteria:

  1. The level of chorionic gonadotropin (HCG) was static or decreased by ultrasonography;
  2. multiple pregnancy;
  3. Patients with congenital uterine malformations, uterine fibroids and any other uterine disease;
  4. Patients who have chronic diseases or are receiving chronic treatment.

Trial design

200 participants in 2 patient groups

healthy pregnant woman
Description:
healthy pregnant woman
Treatment:
Other: Doppler ultrasound measurement of changes in uterine artery blood flow
Pregnant women with recurrent pregnancy loss
Description:
Spontaneous abortion of three or more consecutive sexual partners
Treatment:
Other: Doppler ultrasound measurement of changes in uterine artery blood flow

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems